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Fluids available for intravenous volume replacement may be either crystalloid or colloid. The fundamental differences between these fluids are their effects on the Starling equation (table  1) which describes fluid flux between the intravascular and interstitial spaces. Starling stated that the rate of fluid movement into or out of a capillary is related to the net hydrostatic pressure minus the net colloid osmotic pressure. 1 The Starling equation has been modified to include coefficients which represent the permeability of the capillary membrane to small solutes (Kfc) and its ability to prevent large molecules such as plasma proteins from crossing it (oc).' Colloids may be used to replenish the oncotic strength of the blood, thereby enhancing its water retaining capacity.
Crystalloid versus colloid controversy Colloids are widely used in Europe for volume replacement, while crystalloids are the fluids of choice in many centres in the USA,3 but the relative merits of the two methods of management remain controversial.4 5 Workers in favour of colloids insist that the intravascular colloid osmotic pressure must be kept either above the capillary hydrostatic pressure or at least greater than 10 mm Hg in critically ill patients to avoid a poor prognosis. ' The interstitial space fills more readily after crystalloid resuscitation. Because of this, the volume of fluid required is two to three times greater than when using colloids, resulting in an increased risk of tissue oedema. Sponsors of the crystalloid school maintain that this is not harmful despite the fact that tissue oedema has been associated with tissue hypoxia and has been implicated in delayed healing of bowel anastomoses." Despite the increased volumes required, crystalloid resuscitation is cheaper than the colloid equivalent (table 2) .
Velanovich analysed the mortality data from a number of clinical trials and concluded that after trauma, or in instances when the capillaries are likely to have increased permeability, resuscitation is best achieved with crystalloids.12 In other circumstances-such as during major elective surgery-mortality rates may be reduced by using colloids.
The most appropriate resuscitation regimens undoubtedly involve the use of both crystalloids and colloids. Criteria for volume administration include tachycardia, hypotension, low filling pressures, reduced urine output, metabolic acidosis and increasing core-peripheral temperature gradient, although it should be remembered that a child can maintain a normal heart rate and systemic blood pressure despite a 25% loss of circulating volume. Volume administration should not be based on reflex prescribing-'He looks volume depleted, therefore give 10 ml/kg of plasma'. An individual patient's fluid requirements should be based on the aetiology of the volume depletion, and the most appropriate fluids should be used in adequate volumes.
Intravenous fluids available

CRYSTALLOIDS
(1) Dextrose Because dextrose is rapidly metabolised after intravenous administration, 5% or 10% dextrose solutions act as free water, quickly equilibrating they contain molecules with a wide range of molecular weights, the smallest of which will be rapidly excreted by the kidneys, with the largest being taken up by macrophages of the reticulendothelial system. The greater the degree of substitution by hydroxyethyl groups, the more resistent the molecule is to breakdown by amylase and, therefore, the longer the survival within the body and the circulation.
Of the available HES solutions, the highest degree of substitution (seven hydroxyethyl groups per 10 of glucose) is seen in hetastarch (Hespan, Du Pont). Its intravascular effect may last up to 24 hours and its survival within the body is between two and more than 60 days. 8 24 25 Pentastarch (Pentaspan, Du Pont) has recently received a product licence in the UK. It has five groups per 10 of glucose. Although it still contains a large range of molecular sizes, it does not include molecules with a weight greater than a million daltons. This gives the compound the advantage of a shorter persistence within the body, but with a similar efficacy to hetastarch.26 27 By diafiltering pentastarch, all of the molecules with a Mw of less than 100 000 daltons can be removed. This fluid (Pentafraction) is not commercially available, but preliminary animal work has suggested that its use may be associated with a reduction in capillary leak.9 28 29 (C) Dextrans-Because of their high incidence of adverse effects, the dextrans are inappropriate for volume expansion in paediatrics. Release of histamine by the gelatins has been suggested: firstly, because the incidence is higher with urea linked rather than succinylated gelatins (0 1% and 0-05% respectively) and the former has been associated with free di-isocyanate, which causes histamine release; and secondly, the incidence of allergic reactions can be reduced by pretreatment with HI and H2 blockers.33
The overall incidence of anaphylactoid reactions to HES is quoted at 0-08%, the majority of which are mild, although severe reactions have been reported. 34 The dextrans elicit the worst reactions, both in incidence and severity. These are mediated by dextran reactive antibodies which trigger the release of vasoactive mediators,33 and can be reduced by pretreatment with a hapten. The incidence of cardiac arrest associated with the dextrans, together with their adverse effects on haemostasis and interference with the cross matching of blood are the main factors in their unpopularity. (2) Coagulation effects Dilutional effects are seen with all the colloids (except fresh frozen plasma) but the polysaccharides have been associated with abnormalities of haemostasis which are more than simply dilutional. In particular, factor VIII concentrations may be appreciably reduced. 35 Although in vitro tests may be altered by HES, the effects are rarely of clinical significance3138 unless massive volumes are infused. 39 The coagulation effects of the dextrans are more pronounced, and the dextrans are therefore used to reduce the incidence of postoperative venous thrombosis and fatal pulmonary embolism.40 As these complications are exceedingly rare in general paediatric surgery, they do not provide an indication for the use of dextrans in infants and children, although dextran 40 is used in the postoperative period after orthotopic liver transplantation in an attempt to reduce thrombotic complications in the anastomosed vessels.4' (3) Risks of infection The albumin solutions used in the UK are prepared from donated blood which is screened for antibodies to certain blood borne diseases. Because plasma expanders-that is, they produce an increase in plasma volume greater than the volume of colloid infused. Although this may be of clinical benefit, the risk of fluid overload and significant haemodilution is greater when administered by unwary prescribers.
Conclusions
Although there are certain indications for natural colloids-for example, after certain open heart operations when massive colloid infusion may be required, synthetic colloids could often be given in their place. Because of their safety, the gelatins (particularly the modified fluid gelatins) are the most appropriate choice but there are situations when the superior plasma expansion of hydroxyethyl starches may be required. Although studies with synthetic colloids in adult patients may be extrapolated to the paediatric population, there remains a need for an evaluation of synthetic colloids in paediatric practice.
